Stock Message Board http://investorshangout.com/search?q=GALT&...mp;yt1=Go!
Last Updated: Saturday, January 11, 2014 11:14:26 PM
Galectin Therapeutics Inc. GALT Current Price and Quotes
Last Price 15.10
Previous Close 13.491 Open 17.02
Daily Range 17.88 - 14.78 52wk Range 14.20 - 1.99
Volume 7,253,050 Dividend N/A
Average Vol (3m) 418,253 Yield N/A
Galectin Therapeutics Inc. GALT
Company Information
7 Wells Avenue
Newton, MA 02459
Website: http://www.galectintherapeutics.com
Phone: 617-559-0033
Email: info@galectintherapeutics.com
Galectin Therapeutics Inc. GALT
Galectin Therapeutics (OTC: GALT) is developing promising carbohydrate-based therapies for fibrotic liver disease and cancer based on the Company?s unique understanding of galectin proteins, key mediators of biologic function. We are leveraging extensive scientific and development expertise as well as established relationships with external sources to achieve cost effective and efficient development. We are pursuing a clear development pathway to clinical enhancement and commercialization for o...
Galectin Therapeutics Inc. GALT
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Latest Report Sep 30, 2013 10-Q
CIK 0001133416
Fiscal Year End 12/31
OTC Marketplace Not Available
Profile Data
SIC - Industry Classification Not Available
Business Status Development Stage Company a/o Jul 27, 2011
Incorporated In: NV, USA
Year of Inc. 2000
Employees 7 a/o Jul 27, 2011
Company Notes
Formerly=Pro-Pharmaceuticals, Inc. until 6-2011
Service Providers
Auditor/Accountant
McGladrey & Pullen, LLP
One Valley Square, Suite 250
512 Township Line Rd.
Blue Bell, PA, 19422-2700
United States
Legal Counsel
McCarter English
265 Franklin Street
Boston, MA, 02110
United States
Investor Relations Firm
Not Available
Galectin Therapeutics Inc. GALT
GALT Security Details Other Company Securities
Share Structure
Market Value1 $218,461,778 a/o Jan 10, 2014
Shares Outstanding 18,311,968 a/o Nov 08, 2013
Float Not Available
Authorized Shares Not Available
Par Value 0.001
Shareholders
Shareholders of Record Not Available
Security Notes
New Issue=4-02 2,650,462 shs at $3.50 by the company
Note = delisted from NYSE Alternext on 01/12/09
Capital Change=shs decreased by 1 for 6 split. Pay date=03/23/2012.
Short Selling Data
Short Interest 0 (-100%)
Mar 30, 2012
Significant Failures to Deliver No
Transfer Agent(s)
Continental Stock Transfer & Trust Company
Galectin Therapeutics Inc. GALT Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development 4,527 3,552 1,066 1,110
Sales, General and Admin. 5,372 6,857 3,817 4,983
Non-Recurring Items - - - -
Other - - - -
Operating Income (9,899) (10,409) (4,883) (6,093)
Income From Continuing Operations
Add'l Income/Expense Items 224 (506) (746) (1,369)
Earnings Before Interest and Tax (9,675) (10,915) (5,629) (7,462)
Interest Expense - - - -
Earnings Before Tax (9,675) (10,915) (5,629) (7,462)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (9,675) (10,915) (5,629) (7,462)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (9,675) (10,915) (5,629) (7,462)
Preferred Stock and Other Adjustments (1,206) (1,798) (3,080) (1,957)
Net Income Applicable to Common Shareholders (10,881) (12,713) (8,709) (9,419)
Galectin Therapeutics Inc. GALT Recent News
Jan 10, 2014 Galectin Therapeutics Announces Update on Financing Activities and Cash of $32.3 Million
Jan 8, 2014 Galectin Therapeutics Reports on Key 2013 Scientific, Development and Regulatory Milestones, Highlights Corporate and Financial Activity
Jan 7, 2014 Galectin Therapeutics Receives Patent for Combination Treatment for Liver Fibrosis
Jan 6, 2014 Galectin Therapeutics Receives US Patent for Combination Treatment for Liver Fibrosis
Dec 20, 2013 Obesity Stock Plays Standing Out from the Crowd
Dec 19, 2013 Published Preclinical Study Demonstrates Therapeutic Effect of Galectin Inhibitors in Fatty Liver Disease With Fibrosis
Dec 2, 2013 Galectin Therapeutics Exclusive Interview for the Interlinked Investment News Channel on InterlinkedTV
Nov 12, 2013 Galectin Therapeutics Reports Update on Enrollment of First Cohort of Phase 1 Clinical Trial and Third Quarter 2013 Financial Results
Nov 4, 2013 10X Fund Issues Statement on Exercise of Additional 200,000 Galectin Therapeutics Warrants
Oct 17, 2013 10X Fund Issues Statement on Sale of Shares, Bullish Outlook Regarding Galectin Therapeutics
1
2
next >
GALT Galectin Therapeutics Inc. Research DD Guide
Stock Message Board http://investorshangout.com/search?q=GALT&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/GALT/quote
Stock Chart http://www.otcmarkets.com/stock/GALT/chart
Company Info http://www.otcmarkets.com/stock/GALT/company-info
Recent News http://www.otcmarkets.com/stock/GALT/news
Financials http://www.otcmarkets.com/stock/GALT/financials
Filings and Disclosure http://www.otcmarkets.com/stock/GALT/filings
Short Sales http://www.otcmarkets.com/stock/GALT/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/GALT/insider-transactions
Research Reports http://www.otcmarkets.com/stock/GALT/research
Summary http://finance.yahoo.com/q?s=GALT
Historical Prices http://finance.yahoo.com/q/hp?s=GALT+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=GALT
Basic Chart http://finance.yahoo.com/q/bc?s=GALT+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=GALT+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=GALT+Headlines
Press Releases http://finance.yahoo.com/q/p?s=GALT+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=GALT+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=GALT+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=GALT+Industry
Major Holders http://finance.yahoo.com/q/mh?s=GALT+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=GALT+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=GALT+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=GALT
Balance Sheet http://finance.yahoo.com/q/bs?s=GALT
Cash Flow http://finance.yahoo.com/q/cf?s=GALT+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/GALT
Market Watch http://www.marketwatch.com/investing/stock/GALT
Bloomberg http://www.bloomberg.com/quote/GALT:US
Morningstar http://quotes.morningstar.com/stock/s?t=GALT
Bussinessweek http://investing.businessweek.com/research/st...icker=GALT
Barchart http://www.barchart.com/quotes/stocks/GALT
OTC Short Report http://otcshortreport.com/index.php?index=GALT
Investopedia http://www.investopedia.com/markets/stocks/GALT/?wa=0